ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · IEX Real-Time Price · USD
18.97
+0.20 (1.07%)
Jul 22, 2024, 10:09 AM EDT - Market open
ArriVent BioPharma Employees
ArriVent BioPharma had 40 employees as of December 31, 2023.
Employees
40
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,864,450
Market Cap
640.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pediatrix Medical Group | 5,450 |
| PetIQ | 1,933 |
| Ginkgo Bioworks Holdings | 1,218 |
| REGENXBIO | 344 |
| Prime Medicine | 234 |
| IGM Biosciences | 224 |
| Entrada Therapeutics | 159 |
| KalVista Pharmaceuticals | 150 |
AVBP News
- 6 weeks ago - ArriVent Announces a Multi-Target ADC Collaboration with Alphamab - GlobeNewsWire
- 2 months ago - ArriVent Appoints John Hohneker, M.D., to its Board of Directors - GlobeNewsWire
- 2 months ago - ArriVent BioPharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - ArriVent Appoints Kristine Peterson to its Board of Directors - GlobeNewsWire
- 4 months ago - InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib - Business Wire
- 4 months ago - ArriVent BioPharma Reports Full Year 2023 Financial Results - GlobeNewsWire
- 6 months ago - ArriVent Announces Pricing of Upsized Initial Public Offering - GLOBE NEWSWIRE
- 7 months ago - Cancer biotech ArriVent Biopharma files for a $100 million IPO - Renaissance Capital